Information  X 
Enter a valid email address

IQE PLC (IQE)

  Print      Mail a friend       Annual reports

Tuesday 05 March, 2019

IQE PLC

IQE plc: Holding(s) in Company

IQE plc: Holding(s) in Company

05 March 2019

IQE plc
(“IQE” or the “Company”)

Holding(s) in Company

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:IQE PLC
1b. Please indicate if the issuer is a non-UK issuer (please mark with an “X” if appropriate)
Non-UK issuer 
2. Reason for the notification (please mark the appropriate box or boxes with an “X”)
An acquisition or disposal of voting rights 
An acquisition or disposal of financial instruments 
An event changing the breakdown of voting rightsX
Other (please specify)iii 
3. Details of person subject to the notification obligationiv
NameT. Rowe Price Associates, Inc.
City and country of registered office (if applicable)Baltimore, Maryland, USA
4. Full name of shareholder(s) (if different from 3.)v
NameT. Rowe Price International Ltd
City and country of registered office (if applicable)London, United Kingdom
5. Date on which the threshold was crossed or reachedvi:28 February 2019
6. Date on which issuer notified (DD/MM/YYYY):04 March 2019
7. Total positions of person(s) subject to the notification obligation
 % of voting rights attached to shares (total of 8. A)% of voting rights through financial instruments 
(total of 8.B 1 + 8.B 2)
Total of both in % (8.A + 8.B)Total number of voting rights of issuervii
Resulting situation on the date on which threshold was crossed or reached10.48%4.80%15.29%777,878,204
Position of previous notification (if 
applicable)
10.18%5.16%15.34% 



8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii
A: Voting rights attached to shares
Class/type of
shares

ISIN code (if possible)
Number of voting rightsix% of voting rights
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
Direct
(Art 9 of Directive 2004/109/EC) (DTR5.1)
Indirect
(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0009619924 81,586,423 10.48%
     
     
SUBTOTAL 8. A81,586,423 
 

 
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrumentExpiration
date
x
Exercise/ 
Conversion Period
xi
Number of voting rights that may be acquired if the instrument is 
exercised/converted.
% of voting rights
Shares on loanN/ARight of recall on demand37,412,9234.80%
     
     
  SUBTOTAL 8. B 137,412,9234.80%
 

 
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrumentExpiration
date
x
Exercise/ 
Conversion Period 
xi
Physical or cash 
settlementxii
Number of voting rights% of voting rights
      
      
      
   SUBTOTAL 8.B.2  
 

 

 


9. Information in relation to the person subject to the notification obligation (please mark the 
applicable box with an “X”)
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii 
Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)
X
Namexv% of voting rights if it equals or is higher than the notifiable threshold% of voting rights through financial instruments if it equals or is higher than the notifiable thresholdTotal of both if it equals or is higher than the notifiable threshold
 T. Rowe Price Associates, Inc.5.76%0.30%6.06%
 T. Rowe Price International Ltd4.72%4.50%9.23%
    
    
    
 
10. In case of proxy voting, please identify:
Name of the proxy holder 
The number and % of voting rights held 
The date until which the voting rights will be held 
 
11. Additional informationxvi
 


Place of completionBaltimore, Maryland, USA
Date of completion04 March 2019

a d v e r t i s e m e n t